Indivior Pharmaceuticals INDV
NASDAQ INDV
$38.06 -0.98 (-2.51%)
At close: Aug 20, 2026 · 1:47 PM UTC

Indivior Pharmaceuticals (INDV) Gross Margin (2024 - 2026)

Indivior Pharmaceuticals (INDV) posted quarterly Gross Margin of 87.38% for Q1 2026, up 430.0% year-over-year from 16.49% in Q1 2025, and up 7.13% quarter-over-quarter from 81.56% in Q4 2025.

Indivior Pharmaceuticals (INDV) Gross Margin (2024 - 2026) Analysis & Trends

Indivior Pharmaceuticals' Gross Margin history runs 3 years deep, the most recent figure standing at 87.38% for Q1 2026.

  • In Q1 2026, Gross Margin rose 430.0% year-over-year to 87.38%; the TTM figure through Mar 2026 stood at 81.25% (up 166.0% YoY), while the FY2025 annual figure was 80.23%, down 33.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 87.38%, up from 81.56% in the prior quarter.
  • The five-year high for Gross Margin was 87.38% in Q1 2026, with the low at 73.25% in Q3 2025.
  • The 3-year median for Gross Margin is 82.78% (2025), against an average of 81.15%.
  • Peak annual rise in Gross Margin reached 920 bps in 2025, while the deepest fall reached 525 bps in 2025.
  • Indivior Pharmaceuticals' Gross Margin stood at 83.61% in 2024, then decreased by 2 bps to 81.56% in 2025, then grew by 7 bps to 87.38% in 2026.
  • Business Quant data shows INDV's Gross Margin at 87.38% in Q1 2026, 81.56% in Q4 2025, and 73.25% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn 51.98%
3 Zoetis 31.54 Bn 29.86 Bn 1.05 Bn 42.63%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 66.66%
5 United Therapeutics 22.19 Bn 19.53 Bn 683.80 Mn 87.30%
6 Viatris 18.68 Bn 17.79 Bn 1.46 Bn 38.77%
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn 97.58%
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 58.33%
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Indivior Pharmaceuticals 4.54 Bn 4.32 Bn 294.00 Mn 85.71%

Historic Data

Download Data
DateValue
Jun 30, 2026 85.71%
Mar 31, 2026 87.38%
Dec 31, 2025 81.56%
Sep 30, 2025 73.25%
Jun 30, 2025 82.78%
Mar 31, 2025 83.08%
Dec 31, 2024 83.61%
Sep 30, 2024 78.50%
Jun 30, 2024 73.58%
Mar 31, 2024 86.62%